Moyamoya syndrome with primary antiphospholipid syndrome

被引:8
|
作者
Shuja-Ud-Din, Mohammed Ali
Ahamed, Shefeek Abubacker
Baidas, Ghassan
Naeem, Mohammad
机构
[1] Al Sabah Hosp, Dept Med, Safat, Kuwait
[2] Al Sabah Hosp, Dept Clin Radiol, Safat, Kuwait
关键词
moyamoya disease; antiphospholipid syndrome; stroke;
D O I
10.1159/000092190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To report a rare case of moyamoya syndrome with primary antiphospholipid syndrome (APS). Clinical Presentation and Intervention: A 41-year-old woman was admitted with sudden onset of left-sided hemiparesis. Magnetic resonance imaging and magnetic resonance angiography of the brain showed characteristic features of moyamoya vessels. Laboratory investigations revealed raised levels of anticardiolipin antibody. She made a complete and uneventful recovery with aspirin and intensive physiotherapy over a period of 2 weeks. Conclusion: The association of APS and moyamoya disease may present a dilemma in management. While APS is often considered to be an indication for giving anticoagulation, a trial of antiplatelet agents is preferable to anticoagulation because of the risk of bleeding from the fragile moyamoya vessels. Copyright (C) 2006 S. Karger AG, Basel.
引用
收藏
页码:238 / 241
页数:4
相关论文
共 50 条
  • [21] Editorial: Primary Antiphospholipid Syndrome
    Serrano, Antonio
    Cervera, Ricard
    Gris, Jean Christophe
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [22] Atherosclerosis in primary antiphospholipid syndrome
    Ames, P. R. J.
    Margarita, A.
    Lopez, L.
    Matsuura, E.
    Antinolfi, I.
    Scenna, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 132 - 132
  • [23] Atherosclerosis in primary antiphospholipid syndrome
    Ames, Paul R. J.
    Scenna, Giovanna
    Antinolfi, Iolanda
    Lopez, Luis
    Iannaccone, Luigi
    Matsuura, Eiji
    Margarita, Annamaria
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (01) : 53 - 60
  • [24] CHOREA AND PRIMARY ANTIPHOSPHOLIPID SYNDROME
    VANDENHOOGEN, FHJ
    VANHEEREVELD, HAEM
    FISELIER, T
    BOERBOOMS, AMT
    VANDEPUTTE, LBA
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S359 - S359
  • [25] Belimumab in primary antiphospholipid syndrome
    Yazici, A.
    Yazirli, B.
    Erkan, D.
    LUPUS, 2017, 26 (10) : 1123 - 1124
  • [26] THE DEVASTATING PRIMARY ANTIPHOSPHOLIPID SYNDROME
    ARENAS, MD
    RIVERA, F
    ALBERO, MD
    TORRALBA, J
    FRANCO, A
    MARCO, P
    OLIVARES, J
    NEFROLOGIA, 1995, 15 (04): : 375 - 378
  • [27] Atherosclerosis in primary antiphospholipid syndrome
    Ames, PRJ
    Margarita, A
    Iannaccone, L
    Scenna, G
    Brancaccio, V
    THROMBOSIS RESEARCH, 2004, 114 (5-6) : 625 - 626
  • [28] HYPERTENSION IN PRIMARY ANTIPHOSPHOLIPID SYNDROME
    Baron, M. A.
    Karim, Y.
    Cuadrado, M. J.
    Bertolaccini, L.
    Khamashta, M. A.
    Hughes, G. R. V.
    RHEUMATOLOGY, 2004, 43 : 106 - 106
  • [29] Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?
    Belizna, Cristina
    Stojanovich, Ljudmila
    Cohen-Tervaert, Jan Willem
    Fassot, Celine
    Henrion, Daniel
    Loufrani, Laurent
    Nagy, Gyorgy
    Muchardt, Christian
    Hasan, Milena
    Ungeheuer, Marie Noelle
    Arnaud, Laurent
    Alijotas-Reig, Jaume
    Esteve-Valverde, Enrique
    Nicoletti, Ferdinando
    Saulnier, Patrick
    Godon, Alban
    Reynier, Pascal
    Chretien, Jean Marie
    Damian, Laura
    Omarjee, Loukman
    Mahe, Guillaume
    Pistorius, Marc Antoine
    Meroni, Pier Luigi
    Devreese, Katrien
    AUTOIMMUNITY REVIEWS, 2018, 17 (08) : 739 - 745
  • [30] Primary antiphospholipid syndrome with and without Sneddon's syndrome
    Muniz Caldas, Cezar Augusto
    de Carvalho, Jozelio Freire
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (02) : 197 - 200